TALC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Talc, and when can generic versions of Talc launch?
Talc is a drug marketed by Sciarra Labs and is included in one NDA.
The generic ingredient in TALC is talc. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the talc profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Talc
A generic version of TALC was approved as talc by SCIARRA LABS on December 15th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TALC?
- What are the global sales for TALC?
- What is Average Wholesale Price for TALC?
Summary for TALC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 10 |
| Patent Applications: | 1,817 |
| Drug Prices: | Drug price information for TALC |
| DailyMed Link: | TALC at DailyMed |
Medical Subject Heading (MeSH) Categories for TALC
US Patents and Regulatory Information for TALC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciarra Labs | TALC | talc | POWDER;INTRAPLEURAL | 021388-001 | Dec 15, 2003 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
